FINV Q4 2025 Earnings EPS Reported at 172 Stock Declines Amid Incomplete Disclosure SYPR Q3 2025 Earnings Return to Profitability with EPS of 002 ATLCP Q1 2026 Earnings EPS Surges Past Estimates as Profitability Strengthens PRAX Q1 2026 Earnings Narrowerthanexpected loss as Praxis Precision Medicines advances pipeline CNO Q1 2026 Earnings EPS Beats Estimates by Nearly 11 Despite Modest Stock Decline SCVL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Retail Environment